EMD-44872

Single-particle
3.36 Å
EMD-44872
3D View Gallery
Deposition: 13/05/2024
Map released: 18/12/2024
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-44872

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9bsu summary report (pdf.gz) Map-9bsu FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

EBOV GP/Nanosota-EB1

EMD-44872

Single-particle
3.36 Å
EMD-44872
3D View Gallery
Deposition: 13/05/2024
Map released: 18/12/2024
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus, Vicugna pacos
Sample: EBOV GP/Nanosota-EB1 complex
Fitted models: 9bsu

Deposition Authors: Bu F, Ye G, Liu B , Li F
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.
Bu F, Ye G, Morsheimer K , Mendoza A, Turner-Hubbard H, Herbst M, Spiller B, Wadzinski BE, Eaton B, Anantpadma M, Yang G, Liu B , Davey R, Li F
(2024) PLoS Pathog , 20 , e1012817 - e1012817
PUBMED: 39715280
DOI: doi:10.1371/journal.ppat.1012817
ISSN: 1553-7374